Event Details
AD/PD 2021 Virtual Presentation: “Results of Phase 2 Huntington’s Disease Trial of Anti-Semaphorin 4D Antibody Pepinemab (SIGNAL) Will Guide Clinical Trial in Alzheimer’s Disease”
03/09/21 at 2:00 AM EST
Title
AD/PD 2021 Virtual Presentation: “Results of Phase 2 Huntington’s Disease Trial of Anti-Semaphorin 4D Antibody Pepinemab (SIGNAL) Will Guide Clinical Trial in Alzheimer’s Disease”
Date / Time
03/09/21 at 2:00 AM EST